D.A. has received grants from Nestle Health Sciences and the Weston Family Foundation, Consulting fees from the Canadian Partnership Against Cancer (CPAC) and The Scripps Research Institute, honoraria from Viatris, Takeda and Fresenius Kabi, payment for expert testimony from McCarthy Tetrault and Dives, Harper, Stanger & Mizrahi, support for attending meetings from the CPAC European Commission on Colorectal Cancer and International Working Group for the Classification of Oesophagitis (IWGCO), holds patents from A.I. VAL:I Inc., advisory board participation with Sanofi (honorarium), Cinclus Pharma (no payment), Phathom Pharma (no payment), and Takeda Canada (honorarium), leadership roles with Canadian Digestive Health Foundation, IWGCO and A.I. VALI Inc. K.C. is paid as the Executive Director of the Canadian Digestive Health Foundation. J.M. has received honoraria for lectures by Abbvie, support for attending meettings from Abbvie, for participation on advisory boards for Abbvie, BioJamp, Pfizer, and Cellitron, and is the VP Administrative Affairs for the Canadian Association of Gastroenterology. P.S. is paid consulting fees as Managing Editor for the Journal of the Canadian Association of Gastroenterology. H.S. has received consulting fees from Pendopharm Canada, Ferring Canada, Amgen Canada, Sandoz Canada, Takeda Canada, Bristol-Myers Squibb Canada, Guardant Health, and Abbvie Canada. N.S. has received honoraria for lectures from Pharmascience and Boston Scientific. Nothing to disclose for all other authors.